BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2329275)

  • 1. Alterations in antibody-dependent cellular cytotoxicity during the course of HIV-1 infection. Humoral and cellular defects.
    Tyler DS; Stanley SD; Nastala CA; Austin AA; Bartlett JA; Stine KC; Lyerly HK; Bolognesi DP; Weinhold KJ
    J Immunol; 1990 May; 144(9):3375-84. PubMed ID: 2329275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deficient antibody-dependent cellular cytotoxicity against human immunodeficiency virus (HIV)-expressing target cells in perinatal HIV infection.
    Ziegner U; Campbell D; Weinhold K; Frank I; Rutstein R; Starr SE
    Clin Diagn Lab Immunol; 1999 Sep; 6(5):718-24. PubMed ID: 10473524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knowns and Unknowns of Assaying Antibody-Dependent Cell-Mediated Cytotoxicity Against HIV-1.
    Lewis GK; Ackerman ME; Scarlatti G; Moog C; Robert-Guroff M; Kent SJ; Overbaugh J; Reeves RK; Ferrari G; Thyagarajan B
    Front Immunol; 2019; 10():1025. PubMed ID: 31134085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of antibody-dependent cell cytotoxicity function in HIV-1 antibodies.
    Doepker LE; Danon S; Harkins E; Ralph DK; Yaffe Z; Garrett ME; Dhar A; Wagner C; Stumpf MM; Arenz D; Williams JA; Jaoko W; Mandaliya K; Lee KK; Matsen FA; Overbaugh JM
    Elife; 2021 Jan; 10():. PubMed ID: 33427196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved HIV-positive infant survival is correlated with high levels of HIV-specific ADCC activity in multiple cohorts.
    Yaffe ZA; Naiman NE; Slyker J; Wines BD; Richardson BA; Hogarth PM; Bosire R; Farquhar C; Ngacha DM; Nduati R; John-Stewart G; Overbaugh J
    Cell Rep Med; 2021 Apr; 2(4):100254. PubMed ID: 33948582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Humoral and cellular immune reactions against tumor cells in patients with urinary bladder carcinoma. Correlation between direct and antibody-dependent cell-mediated cytotoxicity.
    Hansson Y; Paulie S; Larsson A; Lundblad ML; Perlmann P; Näslund I
    Cancer Immunol Immunother; 1983; 16(1):23-9. PubMed ID: 6556949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased Fc receptor expression on innate immune cells is associated with impaired antibody-mediated cellular phagocytic activity in chronically HIV-1 infected individuals.
    Dugast AS; Tonelli A; Berger CT; Ackerman ME; Sciaranghella G; Liu Q; Sips M; Toth I; Piechocka-Trocha A; Ghebremichael M; Alter G
    Virology; 2011 Jul; 415(2):160-7. PubMed ID: 21565376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization of Small Molecules That Sensitize HIV-1 Infected Cells to Antibody-Dependent Cellular Cytotoxicity.
    Grenier MC; Ding S; Vézina D; Chapleau JP; Tolbert WD; Sherburn R; Schön A; Somisetti S; Abrams CF; Pazgier M; Finzi A; Smith AB
    ACS Med Chem Lett; 2020 Mar; 11(3):371-378. PubMed ID: 32184972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of Humoral Alloimmunity in Mixed Lymphocyte Reaction.
    Pissas G; Eleftheriadis T
    Bio Protoc; 2019 Jan; 9(2):e3139. PubMed ID: 33654885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reconstruction of a polyclonal ADCC antibody repertoire from an HIV-1 non-transmitting mother.
    Yaffe ZA; Ding S; Sung K; Chohan V; Marchitto L; Doepker L; Ralph D; Nduati R; Matsen FA; Finzi A; Overbaugh J
    iScience; 2023 May; 26(5):106762. PubMed ID: 37216090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bracing NK cell based therapy to relegate pulmonary inflammation in COVID-19.
    Jeyaraman M; Muthu S; Bapat A; Jain R; Sushmitha ES; Gulati A; Channaiah Anudeep T; Dilip SJ; Jha NK; Kumar D; Kesari KK; Ojha S; Dholpuria S; Gupta G; Dureja H; Chellappan DK; Singh SK; Dua K; Jha SK
    Heliyon; 2021 Jul; 7(7):e07635. PubMed ID: 34312598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gp41-targeted antibodies restore infectivity of a fusion-deficient HIV-1 envelope glycoprotein.
    Joshi VR; Newman RM; Pack ML; Power KA; Munro JB; Okawa K; Madani N; Sodroski JG; Schmidt AG; Allen TM
    PLoS Pathog; 2020 May; 16(5):e1008577. PubMed ID: 32392227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influenza A Virus Antibodies with Antibody-Dependent Cellular Cytotoxicity Function.
    Gao R; Sheng Z; Sreenivasan CC; Wang D; Li F
    Viruses; 2020 Mar; 12(3):. PubMed ID: 32121563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monkeying Around: Using Non-human Primate Models to Study NK Cell Biology in HIV Infections.
    Manickam C; Shah SV; Nohara J; Ferrari G; Reeves RK
    Front Immunol; 2019; 10():1124. PubMed ID: 31191520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of HIV gp41-specific antibodies that mediate killing of infected cells.
    Williams KL; Stumpf M; Naiman NE; Ding S; Garrett M; Gobillot T; Vézina D; Dusenbury K; Ramadoss NS; Basom R; Kim PS; Finzi A; Overbaugh J
    PLoS Pathog; 2019 Feb; 15(2):e1007572. PubMed ID: 30779811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody-dependent cellular cytotoxicity in HIV infection.
    Forthal DN; Finzi A
    AIDS; 2018 Nov; 32(17):2439-2451. PubMed ID: 30234611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-specific Fc effector function early in infection predicts the development of broadly neutralizing antibodies.
    Richardson SI; Chung AW; Natarajan H; Mabvakure B; Mkhize NN; Garrett N; Abdool Karim S; Moore PL; Ackerman ME; Alter G; Morris L
    PLoS Pathog; 2018 Apr; 14(4):e1006987. PubMed ID: 29630668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural Killer (NK) Cell Education Differentially Influences HIV Antibody-Dependent NK Cell Activation and Antibody-Dependent Cellular Cytotoxicity.
    Bernard NF; Kiani Z; Tremblay-McLean A; Kant SA; Leeks CE; Dupuy FP
    Front Immunol; 2017; 8():1033. PubMed ID: 28883824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indian Long-term Non-Progressors Show Broad ADCC Responses with Preferential Recognition of V3 Region of Envelope and a Region from Tat Protein.
    Kulkarni A; Kurle S; Shete A; Ghate M; Godbole S; Madhavi V; Kent SJ; Paranjape R; Thakar M
    Front Immunol; 2017; 8():5. PubMed ID: 28154562
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.